Skip to main content
EJNMMI Research
Fig. 3 | EJNMMI Research

Fig. 3

From: First clinical experience with fractionated intracavitary radioimmunotherapy using [177Lu]Lu-6A10-Fab fragments in patients with glioblastoma: a pilot study

Fig. 3

Pretherapeutic [18F]FET-PET/MRI of patient 2 revealed a contrast enhancement adjacent to the resection cavity (arrow) without a relevant [18F]FET hot spot. Whole body images after [99mTc]Tc-DTPA injection did not reveal relevant leakage. During the second cycle post therapeutic images 48 h p.i. showed leakage into the subarachnoid space (arrows). After two cycles of RIT, [18F]FET-PET/MRI marks suspicion of tumor progression (arrow)

Back to article page